Pinterest, Checkpoint Therapeutics And 2 Other Stocks Insiders Are Selling
Portfolio Pulse from Avi Kapoor
Insiders at Pinterest, Checkpoint Therapeutics, ThredUp, and Natera have recently sold shares. Pinterest's stock was positively reviewed by Keybanc, Checkpoint announced a $14 million offering, ThredUp reported disappointing Q3 results, and Natera acquired assets from Invitae.
February 05, 2024 | 2:42 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ThredUp's 10% owner GS Investment Strategies, LLC sold 8,608 shares. The company reported worse-than-expected Q3 financial results.
The insider sale after poor Q3 results might indicate a lack of confidence in the company's short-term recovery.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 85
NEUTRAL IMPACT
Checkpoint Therapeutics CFO William Garrett Gray sold 4,115 shares. The company announced a $14 million registered direct offering.
The insider sale coincides with a significant fundraising effort, which could indicate both a need for capital and potential for future growth.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Natera CFO Michael Burkes Brophy sold 22,281 shares. Natera acquired assets from Invitae's prenatal and carrier screening business.
The acquisition could strengthen Natera's position in prenatal screening, potentially offsetting any negative sentiment from the insider sale.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Pinterest Director Jeffrey D Jordan sold 20,000 shares. Keybanc remains bullish, raising the price target from $37 to $48.
Despite the insider sale, the positive analyst rating and raised price target by Keybanc could lead to short-term bullish sentiment.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90